DK1590373T3 - Konjugater opnået med reduktiv aminering af serotype 5-Pneumococcus-kapsulært polysaccharid - Google Patents

Konjugater opnået med reduktiv aminering af serotype 5-Pneumococcus-kapsulært polysaccharid

Info

Publication number
DK1590373T3
DK1590373T3 DK04702733.9T DK04702733T DK1590373T3 DK 1590373 T3 DK1590373 T3 DK 1590373T3 DK 04702733 T DK04702733 T DK 04702733T DK 1590373 T3 DK1590373 T3 DK 1590373T3
Authority
DK
Denmark
Prior art keywords
aminated
type
conjugates
pneumococcal capsular
serotype
Prior art date
Application number
DK04702733.9T
Other languages
English (en)
Inventor
Emilie Danve
Monique Moreau
Noelle Mistretta
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Application granted granted Critical
Publication of DK1590373T3 publication Critical patent/DK1590373T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
DK04702733.9T 2003-01-17 2004-01-16 Konjugater opnået med reduktiv aminering af serotype 5-Pneumococcus-kapsulært polysaccharid DK1590373T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300488A FR2850106B1 (fr) 2003-01-17 2003-01-17 Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
PCT/FR2004/000089 WO2004067574A1 (fr) 2003-01-17 2004-01-16 Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5

Publications (1)

Publication Number Publication Date
DK1590373T3 true DK1590373T3 (da) 2011-12-05

Family

ID=32605815

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04702733.9T DK1590373T3 (da) 2003-01-17 2004-01-16 Konjugater opnået med reduktiv aminering af serotype 5-Pneumococcus-kapsulært polysaccharid

Country Status (13)

Country Link
US (1) US7812006B2 (da)
EP (1) EP1590373B1 (da)
KR (1) KR101044437B1 (da)
AT (1) ATE520718T1 (da)
AU (1) AU2004207647B2 (da)
BR (1) BRPI0406819B1 (da)
CA (1) CA2512847C (da)
DK (1) DK1590373T3 (da)
FR (1) FR2850106B1 (da)
IL (1) IL169689A0 (da)
MX (1) MXPA05007533A (da)
NZ (1) NZ541254A (da)
WO (1) WO2004067574A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020059A2 (en) * 2000-09-01 2002-03-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN113198012A (zh) 2005-04-08 2021-08-03 惠氏有限责任公司 多价肺炎球菌多糖－蛋白质缀合物组合物
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
US9522382B2 (en) * 2011-09-06 2016-12-20 Biologistics Llc Affinity/lectin chromatography methods
ES2732708T3 (es) * 2011-09-14 2019-11-25 Glaxosmithkline Biologicals Sa Procedimientos de fabricación de glucoconjugados de sacárido-proteína
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
WO2016198170A1 (en) 2015-06-08 2016-12-15 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccines against streptococcus pneumoniae serotype 5
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
WO2018156467A1 (en) * 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Methods for improving filterability of polysaccharide-protein conjugate reactions
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
BR122021023687A8 (pt) 2017-12-06 2023-02-07 Merck Sharp & Dohme Usos de composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae
US20220296695A1 (en) 2018-12-19 2022-09-22 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
EP4243863A2 (en) * 2020-11-10 2023-09-20 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
FR2682388B1 (fr) 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
RU2201421C2 (ru) 1993-06-09 2003-03-27 Коннот Лабораториз Лимитед Синтетический пептид hiv (варианты), иммуногенная композиция для индукции иммунного ответа против пептидов hiv, диагностический набор для определения hiv-специфичных антител
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
EP1035137A1 (en) * 1999-03-12 2000-09-13 Pasteur Merieux Serums Et Vaccins Method for the reductive amination of polysaccharides
DE60032120T2 (de) 1999-03-19 2007-09-20 Glaxosmithkline Biologicals S.A. Impstoff gegen Streptococcus pneumoniae

Also Published As

Publication number Publication date
AU2004207647A1 (en) 2004-08-12
US7812006B2 (en) 2010-10-12
BRPI0406819B8 (da) 2021-05-25
NZ541254A (en) 2008-07-31
FR2850106A1 (fr) 2004-07-23
WO2004067574A1 (fr) 2004-08-12
CA2512847C (en) 2012-08-21
BRPI0406819B1 (pt) 2017-01-03
FR2850106B1 (fr) 2005-02-25
EP1590373A1 (fr) 2005-11-02
AU2004207647B2 (en) 2010-07-01
US20040170638A1 (en) 2004-09-02
BRPI0406819A (pt) 2005-12-27
KR101044437B1 (ko) 2011-06-27
KR20050093838A (ko) 2005-09-23
CA2512847A1 (en) 2004-08-12
EP1590373B1 (fr) 2011-08-17
ATE520718T1 (de) 2011-09-15
IL169689A0 (en) 2007-07-04
MXPA05007533A (es) 2005-12-05

Similar Documents

Publication Publication Date Title
IL169689A0 (en) Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide
CY1108046T1 (el) Μεθοδος για τον καθορισμο προπροϊνσουλινης
AR048035A1 (es) Conjugados de almidon de hidroxialquilo y una proteina, preparados por aminacion reductora
TR200002241T2 (tr) N-Asil siklik amin türevleri
HRP20050353B1 (hr) Polimerski konjugati smanjene antigeniäśnosti, postupci njihova pripravljanja i primjena
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2007113223A3 (en) Immunogenic composition
MX2009007415A (es) Sacaridos modificados.
BR0116022A (pt) Processo para recuperar um composto diidróxi a partir de uma corrente de fluido
AR022963A1 (es) Vacuna
DE50014571D1 (de) Träger-pharmaka-konjugate
PT1282663E (pt) Gel constituido por um poli-alfa-1,4-glucano e amido
FR2751000B1 (fr) Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
WO2007124439A3 (en) Diagnosis of stroke using metalloproteinase or transaminase
SE0402322D0 (sv) Method of preparing a chromatography matrix
TW200718426A (en) Stable lyophilized anthracycline glycosides
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
DE69523296T2 (de) Molkeprotein/polysaccharide Gel, hergestellt durch Hochdruckbehandlung
WO2011084705A2 (en) Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
DK1165489T3 (da) Fremgangsmåde til fremstilling af gabapentin
MY136360A (en) Cyclohexane derivatives and methods for their preparation
CN115671275A (zh) 一种多价脑膜炎球菌多糖结合疫苗的制备方法
CN100398646C (zh) 一种新型亲和载体的制备方法
Roy et al. Michael addition of poly-L-lysine to N-acryloylated sialosides. Syntheses of influenza A virus haemagglutinin inhibitor and group B meningococcal polysaccharide vaccinest
CL2007000839A1 (es) Procedimiento para producir un conjugado que comprende un polisacárido u oligosacárido de tipo 5 u 8 de s. aureus y una proteína portadora; conjugado inmunogénico que lo comprende; vacuna que comprende al conjugado; procedimiento de obtención de dicha vacuna; y uso del conjugado para tratar o prevenir la infección por estafilococos